1. Xu, Ke, Wu, Yuni, Chi, Hao, Li, Xiaosong, Du, Hongjuan. . SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics. In Medicine, 101, e30270. doi:10.1097/MD.0000000000030270. https://pubmed.ncbi.nlm.nih.gov/36123895/
2. Liu, Yangyang, Li, Xiang, Cao, Chang, Zhang, Juyi, Li, Haiying. 2024. Critical role of Slc22a8 in maintaining blood-brain barrier integrity after experimental cerebral ischemia-reperfusion. In Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 45, 85-101. doi:10.1177/0271678X241264401. https://pubmed.ncbi.nlm.nih.gov/39068534/
3. Vávra, Jiří, Mančíková, Andrea, Pavelcová, Kateřina, Bohatá, Jana, Stibůrková, Blanka. 2022. Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort. In Cells, 11, . doi:10.3390/cells11071063. https://pubmed.ncbi.nlm.nih.gov/35406626/
4. Bush, Kevin T, Wu, Wei, Lun, Christina, Nigam, Sanjay K. 2017. The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis. In The Journal of biological chemistry, 292, 15789-15803. doi:10.1074/jbc.M117.796516. https://pubmed.ncbi.nlm.nih.gov/28765282/
5. Wu, Wei, Jamshidi, Neema, Eraly, Satish A, Palsson, Bernhard O, Nigam, Sanjay K. 2013. Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways. In Drug metabolism and disposition: the biological fate of chemicals, 41, 1825-34. doi:10.1124/dmd.113.052647. https://pubmed.ncbi.nlm.nih.gov/23920220/
6. Dahlin, Amber, Wittwer, Matthias, de la Cruz, Melanie, Gupta, Samir K, Giacomini, Kathleen M. . A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome. In Pharmacogenetics and genomics, 25, 82-92. doi:10.1097/FPC.0000000000000110. https://pubmed.ncbi.nlm.nih.gov/25485598/
7. Bhatnagar, Vibha, Xu, Gang, Hamilton, Bruce A, Wu, Wei, Nigam, Sanjay K. 2006. Analyses of 5' regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3). In Journal of human genetics, 51, 575-580. doi:10.1007/s10038-006-0398-1. https://pubmed.ncbi.nlm.nih.gov/16648942/
8. Yee, Sook Wah, Nguyen, Anh Nguyet, Brown, Chaline, Brett, Claire M, Giacomini, Kathleen M. 2013. Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8). In Journal of pharmaceutical sciences, 102, 3451-7. doi:10.1002/jps.23581. https://pubmed.ncbi.nlm.nih.gov/23649425/
智鼠故事 
